Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma
Main Authors: | Cassoux, Nathalie, Rodrigues, Manuel Jorge, Plancher, Corine, Asselain, Bernard, Levy-Gabriel, Christine, Lumbroso-Le Rouic, Livia, Piperno-Neumann, Sophie, Dendale, Rémi, Sastre, Xavier, Desjardins, Laurence, Couturier, Jérôme |
---|---|
Format: | Online |
Language: | English |
Published: |
BMJ Publishing Group
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033183/ |
Similar Items
-
Upcoming translational challenges for uveal melanoma
by: Nabil, Amirouchene-Angelozzi, et al.
Published: (2015) -
Upcoming translational challenges for uveal melanoma
by: Amirouchene-Angelozzi, Nabil, et al.
Published: (2015) -
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma
by: Piperno-Neumann, Sophie, et al.
Published: (2016) -
Retinoblastoma
by: Aerts, Isabelle, et al.
Published: (2006) -
Isolated posterior uveal effusion: expanding the spectrum of the uveal effusion syndrome
by: Pautler, Scott E, et al.
Published: (2014)